Corrigendum to “Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers” [Vaccine 26 (2008) 6671–6677]
Title:
Corrigendum to “Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers” [Vaccine 26 (2008) 6671–6677]
Author:
Guimarães-Walker, A. Mackie, N. McCormack, S. Hanke, T. Schmidt, C. Gilmour, J. Barin, B. McMichael, A. Weber, J. Legg, K. Babiker, A. Hayes, P. Gotch, F. Smith, C. Dally, L. Dorrell, L. Cebere, I. Kay, R. Winstone, N. Moore, S. Goonetilleke, N. Fast, P.